Previous Article | Next Article ![]()
Molecular and Cellular Biology, January 1999, p. 330-341, Vol. 19, No. 1
ONYX Pharmaceuticals, Richmond, California
948061;
Signalling Programme, The
Babraham Institute, Cambridge CB2 4AT, England2;
and
Department of Cell Signalling, DNAX Research Institute,
Palo Alto, California 943043
Received 13 May 1998/Returned for modification 29 June
1998/Accepted 15 September 1998
In Rat-1 fibroblasts nonmitogenic doses of lysophosphatidic acid
(LPA) stimulate a transient activation of mitogen-activated protein
kinase (MAPK), whereas mitogenic doses elicit a sustained response.
This sustained phase of MAPK activation regulates cell fate decisions
such as proliferation or differentiation, presumably by inducing a
program of gene expression which is not observed in response to
transient MAPK activation. We have examined the expression of members
of the AP-1 transcription factor complex in response to stimulation
with different doses of LPA. c-Fos, c-Jun, and JunB are induced rapidly
in response to LPA stimulation, whereas Fra-1 and Fra-2 are induced
after a significant lag. The expression of c-Fos is transient, whereas
the expression of c-Jun, JunB, Fra-1, and Fra-2 is sustained. The early
expression of c-Fos can be reconstituted with nonmitogenic doses of
LPA, but the response is transient compared to that observed with
mitogenic doses. In contrast, expression of Fra-1, Fra-2, and JunB and
optimal expression of c-Jun are observed only with doses of LPA which
induce sustained MAPK activation and DNA synthesis. LPA-stimulated
expression of c-Fos, Fra-1, Fra-2, c-Jun, and JunB is inhibited by the
MEK1 inhibitor PD098059, indicating that the Raf-MEK-MAPK cascade is required for their expression. In cells expressing a conditionally active form of Raf-1 (
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The Repertoire of Fos and Jun Proteins Expressed
during the G1 Phase of the Cell Cycle Is Determined by the
Duration of Mitogen-Activated Protein Kinase Activation
Raf-1:ER), we observed that selective, sustained activation of Raf-MEK-MAPK was sufficient to induce expression of Fra-1, Fra-2, and JunB but, interestingly, induced little
or no c-Fos or c-Jun. The induction of c-Fos observed in response to
LPA was strongly inhibited by buffering the intracellular [Ca2+]. Moreover, although Raf activation or calcium
ionophores induced little c-Fos expression, we observed a synergistic
induction in response to the combination of
Raf-1:ER and ionomycin.
These results suggest that kinetically distinct phases of MAPK
activation serve to regulate the expression of distinct AP-1 components
such that sustained MAPK activation is required for the induced
expression of Fra-1, Fra-2, c-Jun, and JunB. However, in contrast to
the case for Fra-1, Fra-2, and JunB, activation of the MAPK cascade alone is not sufficient to induce c-Fos expression, which rather requires cooperation with other signals such as Ca2+
mobilization. Finally, the identification of the Fra-1, Fra-2, c-Jun,
and JunB genes as genes which are selectively regulated by sustained
MAPK activation or in response to activated Raf suggests that they are
candidates to mediate certain of the effects of Ras proteins in
oncogenic transformation.
*
Corresponding author. Mailing address: Signalling
Programme, The Babraham Institute, Babraham Hall, Cambridge, CB2 4AT,
England, United Kingdom. Phone: (44) 1223-496453. Fax: (44)
1223-496043. E-mail: simon.cook{at}bbsrc.ac.uk.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|